|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
232,105 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,471,016 |
|
|
Indirect Value
|
$4,283,565 |
|
|
Total
Shares |
3,393,580 |
|
|
Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 16 of 17
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CSTL |
Castle Biosciences Inc |
Director |
|
2022-02-10 |
4 |
AS |
$44.42 |
$402,451 |
I/I |
(8,852) |
112,562 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2014-10-30 |
4 |
AS |
$188.02 |
$402,835 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2022-02-09 |
4 |
AS |
$46.33 |
$411,856 |
I/I |
(8,852) |
115,062 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2020-05-20 |
4 |
AS |
$36.84 |
$415,140 |
I/I |
(11,250) |
897,328 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2012-07-26 |
4 |
OE |
$11.95 |
$430,200 |
D/D |
36,000 |
103,615 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-03-25 |
4 |
AS |
$59.93 |
$457,915 |
I/I |
(7,500) |
320,993 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-04-21 |
4 |
AS |
$59.20 |
$468,637 |
I/I |
(7,500) |
298,493 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-03-24 |
4 |
AS |
$61.21 |
$473,147 |
I/I |
(7,500) |
328,493 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-02-16 |
4 |
AS |
$38.25 |
$480,076 |
D/D |
(12,551) |
26,600 |
|
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2024-03-04 |
4 |
AS |
$20.44 |
$482,285 |
I/I |
(23,323) |
25,915 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-04-22 |
4 |
AS |
$63.65 |
$486,658 |
I/I |
(7,500) |
290,993 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2007-03-22 |
4 |
OE |
$2.91 |
$488,911 |
D/D |
39,269 |
52,240 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-02-21 |
4 |
AS |
$39.65 |
$497,647 |
D/D |
(12,551) |
26,600 |
|
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-03-08 |
4 |
AS |
$65.89 |
$505,132 |
I/I |
(7,500) |
343,493 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-02-23 |
4 |
AS |
$41.00 |
$514,632 |
D/D |
(12,552) |
26,600 |
|
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2022-01-24 |
4 |
AS |
$35.37 |
$518,281 |
I/I |
(14,631) |
117,562 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-04-07 |
4 |
AS |
$70.62 |
$537,777 |
I/I |
(7,500) |
305,993 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-02-01 |
4 |
AS |
$26.98 |
$538,820 |
I/I |
(19,826) |
93,840 |
0 |
- |
|
EQ |
Equillium Inc |
Chief Executive Officer |
|
2018-10-16 |
4 |
A |
$11.20 |
$543,144 |
I/I |
48,495 |
2,969,596 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-01-26 |
4 |
AS |
$70.79 |
$544,325 |
I/I |
(7,500) |
380,993 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2022-01-20 |
4 |
AS |
$35.13 |
$550,256 |
I/I |
(15,604) |
121,477 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-01-13 |
4 |
AS |
$71.32 |
$552,216 |
I/I |
(7,500) |
395,993 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-04-06 |
4 |
AS |
$73.54 |
$554,436 |
I/I |
(7,500) |
313,493 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2021-08-18 |
4 |
AS |
$60.59 |
$572,768 |
I/I |
(9,356) |
147,804 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2024-05-06 |
4 |
AS |
$24.64 |
$574,679 |
I/I |
(23,323) |
9,981 |
0 |
- |
|
424 Records found
|
|
Page 16 of 17 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|